In this study, we investigated the prognostic value of ERM (ezrin, moesin) and Rho (RhoA, RhoB and Cdc42) protein expression by immunohistochemical analyses in 85 patients with stage II ductal BC. The gene discussed is EZR; the disease is breast cancer.